← Eichor
Condition: Chronic Phase Of Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Phase Of Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04560322Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Phase 1/Phase 2 · 4 location(s) · Eluciderm Inc · NCT07396376Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Smal
Phase 2 · 7 location(s) · City of Hope Medical Center · NCT07218510Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
NA · 1 location(s) · Fresenius Medical Care Deutschland GmbH · NCT06341452Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI
Phase N/A · 1 location(s) · Odense University Hospital · NCT07511283Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Phase 3 · 41 location(s) · Iperboreal Pharma Srl · NCT03994471A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Phase 3 · 23 location(s) · Amgen · NCT03969329Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and
Phase 1/Phase 2 · 26 location(s) · Sellas Life Sciences Group · NCT04588922Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · 40 location(s) · University Hospital, Tours · NCT05732727BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Phase 2 · 6 location(s) · Dana-Farber Cancer Institute · NCT05922761A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Phase 3 · 125 location(s) · Incyte Corporation · NCT06585774A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
NA · 1 location(s) · Massachusetts General Hospital · NCT05998330Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease
Phase 1 · 1 location(s) · Ottawa Hospital Research Institute · NCT07177833A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia
NA · 1 location(s) · Centre Hospitalier Henri Duffaut - Avignon · NCT06082804A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Phase N/A · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT06126016Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chroni
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06817720Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Phase 1 · 3 location(s) · Tune Therapeutics, Inc. · NCT06671093This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Ord
Phase N/A · 1 location(s) · Sohag University · NCT07144332Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease
Phase N/A · 2 location(s) · National Taiwan University Hospital · NCT05878171Rheopheresis as Adjuvant Treatment of Calciphylaxis
NA · 29 location(s) · University Hospital, Lille · NCT04654000Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1 · 9 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT06980116Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06364423A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrel
Phase 2 · 103 location(s) · Hoffmann-La Roche · NCT07282574SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06173947Neuroimaging of Opioid Phase (OPAL)
NA · 1 location(s) · Duke University · NCT05905419B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide
Phase 1 · 1 location(s) · Mayo Clinic · NCT06191887Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NA · 17 location(s) · C. R. Bard · NCT04634916
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.